Chronic Granulomatous Disease Transplant
Prevalence
0.5 / 100K
5 drugs in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(3)
Phase 2(1)
| Drug | Company |
|---|---|
| Busulfan | Filana Therapeutics Inc. (FLNA) |
Phase 1(1)
| Drug | Company |
|---|---|
| Alemtuzumab | Filana Therapeutics Inc. (FLNA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Chronic Granulomatous Disease Transplant?
BioSniper tracks 5 drugs in development for Chronic Granulomatous Disease Transplant across 1 company.
How many clinical trials target Chronic Granulomatous Disease Transplant?
There are 1 clinical trial targeting Chronic Granulomatous Disease Transplant tracked by BioSniper.
What is the prevalence of Chronic Granulomatous Disease Transplant?
The estimated prevalence of Chronic Granulomatous Disease Transplant is approximately 0.5 per 100,000 population.
Deep-dive into Chronic Granulomatous Disease Transplant
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis